GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
DIC India Ltd
DIC India Ltd: Hayato Kashiwagi Designated MD, Praveen Asthana Appointed Whole-Time Director
MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 15 Jul 2026, 11:38 AM IST  ·  BSE ID: d2b540af-fe8c-4273-9f35-6d5c64f80129
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has appointed new senior leadership, including a Managing Director and a Whole-Time Director.
🤖 AI Summary
  • Hayato Kashiwagi designated Managing Director for 3 years from September 01, 2026.
  • Praveen Kumar Asthana appointed Additional Director, Whole Time Director.
  • Appointments are subject to member and other necessary approvals.
  • Board meeting held on July 15, 2026, approved these management changes.
🏢 How This Affects the Company
📈
Business Impact
This appointment marks a shift in executive leadership, impacting the company's strategic direction and operational oversight.
💰
Financial Impact
No direct financial impact is stated in this filing; financial implications will depend on the performance of the new leadership.
⚙️
Operational Impact
The designation of a Managing Director and Whole-Time Director will redefine roles and responsibilities within the senior management structure.
⚠️
Risk Impact
Management changes can introduce transitional risks, but also provide an opportunity for refreshed strategic focus and execution.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will likely be required to approve these appointments at a future meeting.
👤
Who Is Affected
All shareholders are affected by changes in the company's key managerial personnel, impacting governance and strategic direction.
🔍
Management Signal
The Board's approval of these appointments signifies a commitment to strengthening executive leadership and ensuring continuity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder approval status for appointments
Effective date of appointments for Kashiwagi and Asthana
Subsequent management structure and strategic announcements
LOW RISK The filing reports a routine management change approved by the Board, with no immediate material risks disclosed.
💡 Investor Takeaway
DIC India's Board has approved the appointment of Hayato Kashiwagi as Managing Director for a 3-year term from September 01, 2026, and Praveen Kumar Asthana as Whole-Time Director, subject to approvals.
❓ Frequently Asked Questions
Who has been appointed as the Managing Director of DIC India?
Mr. Hayato Kashiwagi has been designated as the Managing Director of DIC India.
When will Hayato Kashiwagi's term as Managing Director begin?
His term as Managing Director will begin effective September 01, 2026.
What is the tenure of Mr. Kashiwagi's appointment as Managing Director?
Mr. Kashiwagi has been appointed for a term of 3 years.
Who has been appointed as an Additional Director and Whole-Time Director?
Mr. Praveen Kumar Asthana has been appointed as an Additional Director in the capacity of Whole Time Director.
What approvals are required for these appointments?
These appointments are subject to the approval of the Members of the Company and all other relevant approvals as prescribed under applicable law.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.